Article Information
History
- September 2, 2022.
Article Versions
- Version 1 (August 25, 2022 - 14:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Asia-Sophia Wolf*,1,
- Anthony Ravussin*,1,
- Marton König*,2,#,
- Mathias H. Øverås2,
- Guri Solum1,
- Ingrid Fadum Kjønstad1,
- Adity Chopra3,4,
- Trygve Holmøy3,5,
- Hanne F. Harbo2,3,
- Silje Watterdal Syversen6,
- Kristin Kaasen Jørgensen7,
- Einar August Høgestøl2,8,
- Jon Torgils Vaage3,4,
- Elisabeth G. Celius2,3,
- Fridtjof Lund-Johansen3,4,
- Ludvig A. Munthe3,4,9,
- Gro Owren Nygaard†,2 and
- Siri Mjaaland†,1
- 1Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway
- 2Department of Neurology, Oslo University Hospital, Oslo, Norway
- 3Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 4Department of Immunology, Oslo University Hospital, Oslo, Norway
- 5Department of Neurology, Akershus University Hospital, Lørenskog, Norway
- 6Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway
- 7Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway
- 8Department of Psychology, University of Oslo
- 9KG Jebsen Centre for B cell malignancy, University of Oslo, Oslo, Norway
- ↵#Corresponding author: Marton König, Department of Neurology, Oslo University Hospital, PO Box 4956, Nydalen, N-0424 Oslo, Norway (makoni{at}ous-hf.no).